Jim Simons Ionis Pharmaceuticals Inc Transaction History

Renaissance Technologies LLC

$56.7 Billion
Q2 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 249,514 shares of IONS stock, worth $9.46 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

249,514

Previous 179,714 38.84%

Holding current value

$9.46 Million

Previous $7.79 Million 52.62%

% of portfolio

0.02%

Previous 0.01%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$36.45 - $47.7 $2.54 Million - $3.33 Million	69,800 Added 38.84%	249,514 $11.9 Million
Q1 2024 May 13, 2024	BUY	$42.03 - $53.55 $2.83 Million - $3.6 Million	67,300 Added 59.87%	179,714 $7.79 Million
Q4 2023 Feb 13, 2024	SELL	$43.39 - $51.63 $6.83 Million - $8.13 Million	-157,386 Reduced 58.33%	112,414 $5.69 Million
Q3 2023 Nov 14, 2023	SELL	$38.5 - $47.13 $3.88 Million - $4.75 Million	-100,700 Reduced 27.18%	269,800 $12.2 Million
Q2 2023 Aug 11, 2023	SELL	$34.73 - $43.33 $9.23 Million - $11.5 Million	-265,814 Reduced 41.77%	370,500 $15.2 Million
Q1 2023 May 12, 2023	SELL	$33.58 - $41.2 $18.2 Million - $22.4 Million	-542,500 Reduced 46.02%	636,314 $22.7 Million
Q4 2022 Feb 13, 2023	BUY	$37.12 - $46.52 $11.5 Million - $14.5 Million	311,100 Added 35.85%	1,178,814 $44.5 Million
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $9.24 Million - $12.3 Million	252,900 Added 41.13%	867,714 $38.4 Million
Q2 2022 Aug 12, 2022	BUY	$31.71 - $43.0 $15.2 Million - $20.6 Million	479,900 Added 355.71%	614,814 $22.8 Million
Q1 2022 May 13, 2022	SELL	$29.88 - $37.04 $2.87 Million - $3.55 Million	-95,900 Reduced 41.55%	134,914 $5 Million
Q4 2021 Feb 11, 2022	BUY	$25.61 - $35.1 $3.41 Million - $4.67 Million	133,100 Added 136.21%	230,814 $7.02 Million
Q3 2021 Nov 12, 2021	SELL	$33.54 - $40.55 $22.8 Million - $27.5 Million	-678,700 Reduced 87.41%	97,714 $3.28 Million
Q2 2021 Aug 13, 2021	BUY	$34.54 - $47.25 $6.53 Million - $8.93 Million	189,000 Added 32.17%	776,414 $31 Million
Q1 2021 May 13, 2021	SELL	$42.51 - $63.78 $6.71 Million - $10.1 Million	-157,934 Reduced 21.19%	587,414 $26.4 Million
Q4 2020 Feb 10, 2021	SELL	$45.3 - $60.27 $32.7 Million - $43.5 Million	-721,819 Reduced 49.2%	745,348 $42.1 Million
Q3 2020 Nov 13, 2020	SELL	$47.45 - $62.95 $13.6 Million - $18 Million	-285,700 Reduced 16.3%	1,467,167 $69.6 Million
Q2 2020 Aug 13, 2020	BUY	$46.85 - $61.05 $3.02 Million - $3.94 Million	64,456 Added 3.82%	1,752,867 $103 Million
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $14.6 Million - $22.2 Million	-350,300 Reduced 17.18%	1,688,411 $79.8 Million
Q4 2019 Feb 13, 2020	BUY	$53.85 - $65.27 $12.2 Million - $14.7 Million	225,700 Added 12.45%	2,038,711 $123 Million
Q3 2019 Nov 13, 2019	BUY	$59.06 - $72.15 $3.41 Million - $4.16 Million	57,700 Added 3.29%	1,813,011 $109 Million
Q2 2019 Aug 12, 2019	BUY	$62.09 - $86.14 $109 Million - $151 Million	1,755,311 New	1,755,311 $113 Million

Others Institutions Holding IONS

# of Institutions

395

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.38B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account